Sequential modifications of topoisomerase I activity in a camptothecin-resistant cell line established by progressive adaptation

作者: Isabelle Madelaine , Sandrine Prost , Annette Naudin , Guy Riou , François Lavelle

DOI: 10.1016/0006-2952(93)90069-9

关键词:

摘要: The DNA-topoisomerase I (Topo I) inhibitor, camptothecin (CPT), is a plant alkaloid with an important antitumor activity. In order to investigate the cellular mechanism leading development of resistance this agent, we have established by progressive adaptation P388 subline resistant CPT. After 5 months continuous drug exposure, index reached value 20 and cell line, P388CPT0.3, was maintained in presence CPT-induced single strand breaks measured alkaline elution were found drastically reduced line. Topo activity DNA cleavage on cells at different steps resistance. We first observed that strongly decreased. addition, recovered ATP-independent relaxation after 3 exposure CPT, but still kept cleavage. Further evaluations final stage induction indicated presented CPT-resistant form I. Rearranged gene one allele transcription also cells. putative role rearrangement discussed. These data show has evolved from decreased altered enzyme, suggest multiple mechanisms modifications could contribute CPT

参考文章(31)
Mayumi Ono, Michihiko Kuwano, Kimitoshi Kohno, Hiroshi Takano, Yuzo Uchida, Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells. Cancer Research. ,vol. 51, pp. 3951- 3957 ,(1991)
Y H Hsiang, R Hertzberg, S Hecht, L F Liu, Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. Journal of Biological Chemistry. ,vol. 260, pp. 14873- 14878 ,(1985) , 10.1016/S0021-9258(17)38654-4
Yves Pommier, Christine Jaxel, Kurt W. Kohn, Joseph M. Covey, Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Cancer Research. ,vol. 49, pp. 5016- 5022 ,(1989)
Teruo Yokokura, Tadashi Miyasaka, Hiroyasu Baba, Kazuo Nitta, Siego Sawada, Masahiko Mutai, Mieko Takeuchi, Tomiko Tanaka, Nobuaki Uehara, Takehiko Kunimoto, Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors. Cancer Research. ,vol. 47, pp. 5944- 5947 ,(1987)
Fumihiko Kanzawa, Koichi Minato, Kazuhiko Nakagawa, Leroy-Fong Liu, Masami Bungo, Nagahiro Saijo, Yasuhiro Fujiwara, Yoshikazu Sugimoto, Kazuo Kasahara, Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: characterization and mechanism of resistance. Cancer Research. ,vol. 50, pp. 5919- 5924 ,(1990)
Robert P. Hertzberg, Mary Jo Caranfa, Radhey S. Gupta, Randall K. Johnson, Warren E. Ross, Richard B. Lock, Barry Eng, Rajni Gupta, Camptothecin-resistant Mutants of Chinese Hamster Ovary Cells Containing a Resistant Form of Topoisomerase I Cancer Research. ,vol. 48, pp. 6404- 6410 ,(1988)
Dominique Lefevre, Jean-François Riou, Jean Charles Ahomadegbe, Danyi Zhou, Jean Benard, Guy Riou, Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase. Biochemical Pharmacology. ,vol. 41, pp. 1967- 1979 ,(1991) , 10.1016/0006-2952(91)90138-U
Yves Pommier, Akihiko Tanizawa, Topoisomerase I alteration in a camptothecin-resistant cell line derived from Chinese hamster DC3F cells in culture. Cancer Research. ,vol. 52, pp. 1848- 1854 ,(1992)
S Giorgi-Renault, P Helissey, L Grondard, J F Riou, Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives. Molecular Pharmacology. ,vol. 40, pp. 699- 706 ,(1991)
Milan Potmesil, Mansukh C. Wani, Chiang Yu, Allan Y. Chen, Monroe E. Wall, Leroy F. Liu, Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells. Cancer Research. ,vol. 51, pp. 6039- 6044 ,(1991)